SEC Form 4 · accession 0001562180-17-000848
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Federici
Officer — Sr. VP & CFO
Period of report
Feb 21, 2017
Accepted (ET)
Feb 22, 2017 · 3:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F1 | $83.47 | Feb 21, 2017 | A | 19,512 | A | Feb 21, 2018 | Feb 21, 2027 | Common Stock | 19,512 | 19,512 | D |
Explanation of responses
- F1This award vests in 4 equal annual installments beginning on 2/21/2018.